AzTrials
AzTrials

Chronic Low Back PainPhase 1CINSNCT00463970

Cognitive Interventions and Nutritional Supplementation for Patients With Long-lasting Back Pain

A Phase 1 study testing Brief Intervention, Cognitive Behavioural Therapy and Seal oil in people with Chronic Low Back Pain, run by NORCE Norwegian Research Centre AS at 2 sites in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

CINS is a large multicentre study which aims to test out the effect of 4 different interventions, namely a brief cognitive intervention (BI), a more extensive cognitive behavioural intervention (CBT), and 2 different nutritional supplementations (seal oil and soy oil) in a population of chronic low back pain patients… Read more about this study

Who is it for?
Ages 20 to 60 years
Conditions the study is for
Chronic Low Back Pain
What is being tested?
Brief Intervention, Cognitive Behavioural Therapy and Seal oil
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
414 participants
Where
2 sitesNorway
Study dates
Feb 2008to Aug 2012
Phase
Phase 1
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 20 to 60 years
  • All sexes
  • No healthy volunteers
  • Adult

Who may be able to join

  • Patients sicklisted 2-10 months for low back pain
  • The following diagnosis are included: L02, L03, L84 and L86

Who cannot join

  • Being off the sick list
  • Pregnancy
  • Osteoporosis
  • Cancer
  • L diagnoses suggesting recent low back pain trauma
  • Specific spinal or other injuries which may account for the current back pain
  • Serious psychiatric pathology

Trial locations and contacts

2 sites in 1 country.

Norway2 sites
  • Uni Research Health

    Bergen, 5015

  • Torill H Tveito

    Bergen

Other trials in Norway

About this study

Official title: A Randomized Controlled Multicentre Trial of a Brief Intervention (BI) Versus a BI Plus Cognitive Behavioural Treatment (CBT) Versus Nutritional Supplementation for Patients With Long-lasting Back Pain.

CINS is a large multicentre study which aims to test out the effect of 4 different interventions, namely a brief cognitive intervention (BI), a more extensive cognitive behavioural intervention (CBT), and 2 different nutritional supplementations (seal oil and soy oil) in a population of chronic low back pain patients sicklisted for 2-10 months.

Read the detailed description

The treatment principles for low back pain, and also other types of non-specific muscle pain, have changed dramatically over the last 10 to 15 years; from traditional treatment like bed rest and inactivity to more active treatment strategies ("the back pain revolution"; Waddell et al 1997). Norwegian research has been in the forefront, particularly in demonstrating the clinical and cost effective brief interventions (BI) (Indahl et al., 1995, 1998; Hagen et al 2000, 2004, Brox et al 2003, Storheim et al 2003). However, about 30% of the patients do not recover or return to normal social and working life. The aim of this study is therefore to see if a longer cognitive behavioural intervention (CBT) has an additional benefit to BI, and to compare this with a potentially beneficial dietary supplement.

Being tested
Brief Intervention, Cognitive Behavioural Therapy, Seal oil, Soy oil
Keywords
Chronic low back pain, Brief cognitive intervention, Cognitive behavior therapy, Seal oil

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Brief InterventionBehavioural

    Also called Brief Education, Light mobilization treatment

    Physical examination, education and follow up by a physiotherapist

  • Cognitive Behavioural TherapyBehavioural

    Also called Cognitive behavioral treatment, Cognitive rehabilitation

    7 sessions of CBT over a period of 2 months, included a booster session after 3 months

  • Seal oilDietary supplement

    Also called Marine oil, Nutritional supplement

    20 capsules per day for 3 months

  • Soy oilDietary supplement

    Also called Vegetable oil, Nutritional supplement

    20 capsules per day for 3 months

Study groups in NCT00463970
Study groupRoleWhat they receive
1Active comparatorBrief Intervention
Receives: Behavioral: Brief Intervention
2ExperimentalCognitive Behavioural Therapy
Receives: Behavioral: Cognitive Behavioural Therapy
3ExperimentalSeal oil
Receives: Dietary Supplement: Seal oil
4Placebo comparatorSoy oil
Receives: Dietary Supplement: Soy oil

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Sickness leave

    Measured: 2008-2020

Secondary outcomes (4)
  1. Health complaints

    Measured: 2008-2010

  2. Psychopathology

    Measured: 2008-2010

  3. Cortisol curves

    Measured: 2008-2010

  4. Function

    Measured: 2008-2010

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted20 Apr 2007 (estimated)
  2. Study startFeb 2008
  3. Primary completionAug 2010
  4. Study completionAug 2012

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 1
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Quadruple blind
Who is masked
Participant, Care provider, Investigator, Outcomes assessor
Enrolment
414 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT00463970
Sponsor's protocol ID
CINS2007
Acronym
CINS
Status last verified
Feb 2017
First submitted
18 Apr 2007
Last updated
23 Feb 2017
Results posted
No
Data monitoring committee
Yes

Publications

  • Reme SE, Tveito TH, Chalder T, Bjorkkjaer T, Indahl A, Brox JI, Fors E, Hagen EM, Eriksen HR. Protocol for the Cognitive Interventions and Nutritional Supplements (CINS) trial: a randomized controlled multicenter trial of a brief intervention (BI) versus a BI plus cognitive behavioral treatment (CBT) versus nutritional supplements for patients with long-lasting muscle and back pain. BMC Musculoskelet Disord. 2011 Jul 7;12:152. doi: 10.1186/1471-2474-12-152.

    PubMed 21736730
  • Reme SE, Tangen T, Moe T, Eriksen HR. Prevalence of psychiatric disorders in sick listed chronic low back pain patients. Eur J Pain. 2011 Nov;15(10):1075-80. doi: 10.1016/j.ejpain.2011.04.012. Epub 2011 May 17.

    PubMed 21592832
  • Harris A, Endresen Reme S, Tangen T, Hansen AM, Helene Garde A, Eriksen HR. Diurnal cortisol rhythm: Associated with anxiety and depression, or just an indication of lack of energy? Psychiatry Res. 2015 Aug 15;228(2):209-15. doi: 10.1016/j.psychres.2015.04.006. Epub 2015 Apr 24.

    PubMed 26001959
  • Reme SE, Tveito TH, Harris A, Lie SA, Grasdal A, Indahl A, Brox JI, Tangen T, Hagen EM, Gismervik S, Odegard A, Fr Yland L, Fors EA, Chalder T, Eriksen HR. Cognitive Interventions and Nutritional Supplements (The CINS Trial): A Randomized Controlled, Multicenter Trial Comparing a Brief Intervention With Additional Cognitive Behavioral Therapy, Seal Oil, and Soy Oil for Sick-Listed Low Back Pain Patients. Spine (Phila Pa 1976). 2016 Oct 15;41(20):1557-1564. doi: 10.1097/BRS.0000000000001596.

    PubMed 27760062
  • Rosenblom MF, Jacobsen HB, Reme SE. Ready or Not? Applying the Transtheoretical Model of Change on Return-to-Work Following CBT for Chronic Low Back Pain. J Occup Rehabil. 2026 Jul 17. doi: 10.1007/s10926-026-10432-5. Online ahead of print.

    PubMed 42469553
  • Opsahl J, Eriksen HR, Tveito TH. Do expectancies of return to work and Job satisfaction predict actual return to work in workers with long lasting LBP? BMC Musculoskelet Disord. 2016 Nov 17;17(1):481. doi: 10.1186/s12891-016-1314-2.

    PubMed 27855684

Questions about this trial

What is this clinical trial studying?

A Phase 1 study testing Brief Intervention, Cognitive Behavioural Therapy and Seal oil in people with Chronic Low Back Pain, run by NORCE Norwegian Research Centre AS at 2 sites in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Feb 2017. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 1 studies test a treatment in a small group of people for the first time or in a new way, mainly to check safety and find the right dose.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Sickness leave (time frame: 2008-2020). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT00463970, which also lists 6 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Feb 2017.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in